Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
about
Characterization of the mRNA ligands bound by the RNA binding protein hnRNP A2 utilizing a novel in vivo technique.The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.Making (anti)sense of non-coding sequence conservationAn open reading frame element mediates posttranscriptional regulation of tropoelastin and responsiveness to transforming growth factor beta1.Fibrin turnover in lung inflammation and neoplasia.Integrin-dependent regulation of gene expression in leukocytes.Regulation of urokinase expression at the posttranscription level by lung epithelial cells.Regulation of u-PAR gene expression by H2A.Z is modulated by the MEK-ERK/AP-1 pathway.Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.Pathogenesis of pleural fibrosis.The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.Fibrinolysis, inflammation, and regulation of the plasminogen activating system.The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagementStabilization of XIAP mRNA through the RNA binding protein HuR regulated by cellular polyamines.Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2alpha-related factor.beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoterRegulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53.Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover.Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity.Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharideThe protein kinase C beta II exon confers mRNA instability in the presence of high glucose concentrations.Urokinase induces its own expression in Beas2B lung epithelial cells.Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism.The small-GTPase RalA activates transcription of the urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanism.Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs.Post-transcriptional regulation of H-ferritin mRNA. Identification of a pyrimidine-rich sequence in the 3'-untranslated region associated with message stability in human monocytic THP-1 cells.Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis.Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.Regulation of urokinase receptor expression by protein tyrosine phosphatases.Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.Urokinase receptor expression involves tyrosine phosphorylation of phosphoglycerate kinase.Post-transcriptional control of the level of mRNA by hepatitis B virus X gene in the transient expression system using human hepatic cells.Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA.p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis.Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression
P2860
Q30860052-AD6AFE1C-FDF6-4687-B62A-1A85FB03D782Q33199829-2ADAC70E-6EE4-469D-AB67-03CD5951CD5EQ33368236-A2BB69AD-7108-4AB2-9239-60786982159BQ33959906-8494DE69-DC65-4B45-8FBD-FDCF3ECB08B7Q34141236-CD48A609-3963-4098-B6A4-C5B69A6E558EQ34862325-69F06439-5D40-4E5D-ACBF-35F53E1B9E28Q35663478-906F10D9-4E26-42C5-B9EF-D6E8A97CFEDFQ35672193-82FEF32C-99DB-462F-8887-5C09AB8A2B98Q35791732-EDC916BC-5D80-4A43-AA29-EC94B8FA07D7Q35950247-515B0233-03E6-469D-A3DA-2307C92E1038Q35990839-ED352A68-FD64-4C4C-83FE-93D93CD14DFCQ36174568-8F9FCDA7-9160-4C73-8FFE-2857FAAF49B1Q36884356-2D1B38E1-8CA1-4EE4-9335-CBDF3E4195F3Q37286882-6F418040-0CB8-4888-A6EF-84F121ED34B0Q37397424-B1173133-EB27-4EF8-A872-56247089EF07Q37477501-96E9E4DC-59C3-42C9-8F41-8C5DC16FE792Q38328240-3654CA19-05F1-4159-B231-AE0616C49E1AQ39458488-6A8CC348-9C9D-45BA-A93B-021B8D9C32C3Q39680231-BEB89E3B-EC78-4DEB-BD3F-844FC29B0D34Q39682763-BC820AE7-5E3B-4935-A882-81F0EDE1340FQ39994924-CC0407EF-64D0-421A-A4A3-ADDD7D752660Q40171554-58A7F11B-2619-49ED-9DFA-BC7FC6205279Q40410606-B5AB8F73-0598-4A95-9030-631409523320Q40573249-FBB40DE7-E3F1-4097-AFF4-22ADBCB4E37DQ40693549-80457909-18F6-49DF-B27A-A0217BF42D78Q40718884-847340CD-BF7C-4CFD-A7FC-572C48F26A1DQ40765771-40BA15C3-9659-4C57-9498-B45A9730FD75Q40811056-D08F2647-62D2-4827-8B97-A57016002D0EQ40816793-69B3850D-9A91-435B-A4FE-FE4D636D134BQ40924293-440140EA-D322-4F4E-A678-A147DEF1CCAFQ40931728-6C31D47A-5E4A-4C46-80BE-335EC43C6771Q41028790-AE7F3631-A0CA-45CE-A926-96D789ED0CDDQ41569905-DE5A4430-0C01-4936-9EEC-0E0FAECE3D7FQ42502435-6FFA3539-7071-41A4-9355-FC978470A54AQ43180383-F961E411-6431-4A4B-9E4D-1DED46774135Q43270446-F0BCF027-08EC-4010-83B5-B6CF20A3EE80Q45753669-C8FF4D29-2F25-41E2-8EF2-7493EAA114E5Q45861542-8D086E6F-8FB8-4071-9305-E7FE33361CF8Q47955359-23679D46-7A98-48CE-9F07-07FF7D71B37AQ58482772-3FAA1135-6F1A-45D3-8C90-8C661A9966B7
P2860
Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Posttranscriptional regulation ...... n in human mesothelioma cells.
@ast
Posttranscriptional regulation ...... n in human mesothelioma cells.
@en
type
label
Posttranscriptional regulation ...... n in human mesothelioma cells.
@ast
Posttranscriptional regulation ...... n in human mesothelioma cells.
@en
prefLabel
Posttranscriptional regulation ...... n in human mesothelioma cells.
@ast
Posttranscriptional regulation ...... n in human mesothelioma cells.
@en
P2093
P2860
P356
P1476
Posttranscriptional regulation ...... n in human mesothelioma cells.
@en
P2093
P2860
P304
P356
10.1128/MCB.17.3.1075
P407
P577
1997-03-01T00:00:00Z